Continuous Parkinson's Disease Therapy Wins FDA Nod Round-the-clock infusion delivers carbidopa and levodopa pro-drugs Oct 17, 2024
Kids' Neurodevelopment Appears Unharmed by Maternal COVID Infection Study may ease fears about potential neurodevelopmental effects of fetal COVID exposure Oct 17, 2024 video
Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis Phase III trial met primary endpoint at 6 months Oct 16, 2024
Anti-CD19 Monoclonal Antibody Shows Positive Results in Myasthenia Gravis Topline phase III data show inebilizumab met primary endpoint Oct 15, 2024
Alzheimer's-Heparin Link; Two Phases of Alzheimer's Damage; Prion Disease Testing News and commentary from the world of neurology and neuroscience Oct 15, 2024
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of Millions Nearly 6% of lecanemab may be discarded each year Oct 14, 2024
Loneliness Tied to Alzheimer's and Dementia Risk Feeling lonely also linked with cognitive impairment that's not dementia, meta-analysis shows Oct 11, 2024
Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk 10% of patients in trials leading to eli-cel's approval developed MDS or AML Oct 09, 2024
Some Cancers Occur More Frequently in Multiple Sclerosis Patients Bladder, brain, and cervical cancer risks were higher in people with MS Oct 09, 2024
Liberal Blood Transfusions Deliver Brain Function Benefit for the Critically Ill Fewer cerebral ischemic events also observed with care teams quicker to give blood Oct 09, 2024
One Way to Spot Early Cognitive Decline? Medicare Wellness Visits Annual evaluation tied to timelier mild cognitive impairment diagnoses Oct 09, 2024
How the Brain Clears Waste; Masked Benzodiazepine Taper; New Hope for PML News and commentary from the world of neurology and neuroscience Oct 08, 2024
Low-Dose Lithium Tested in Long COVID No benefit for brain fog or fatigue, but higher doses may have promise Oct 02, 2024
Hearing Loss-Cognition Link; Circadian Brain Changes; Repetitive Head Impact Markers News and commentary from the world of neurology and neuroscience Oct 01, 2024
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows In three trials, about 40% of patients with brain metastases recovered neurocognitive function Oct 01, 2024
Brett Favre's Parkinson's: 'Hell, I Wrote the Book on Head Trauma' What we know -- and don't know -- about pro football and brain disorders Sep 27, 2024
NIH Neuroscience Leader Committed Research Misconduct, Agency Says Longtime NIA researcher investigated synaptic damage in neurodegenerative disorders Sep 26, 2024
Sexual and Gender Minorities More Likely to Have Adverse Brain Outcomes Some LGBTQ+ groups have higher likelihood of dementia Sep 25, 2024
Fluoride in Water Poses Enough Risk to Kids' IQ to Merit EPA Action, Judge Says Ruling is a blow to practice hailed as one of the greatest achievements in public health Sep 25, 2024
Second Drug OK'd for Ultra-Rare Neurodegenerative Disease FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C Sep 25, 2024
Flavonoid-Dementia Link; Political Beliefs and the Brain; Ethics of Brain Biopsies News and commentary from the world of neurology and neuroscience Sep 24, 2024
One in Three Former NFL Players Believe They Have CTE About 25% of men who thought they had CTE reported feeling suicidal Sep 23, 2024
McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease Some cases of radiologically isolated syndrome will be considered multiple sclerosis Sep 23, 2024
EPA Scientists Say They Were Pressured to Downplay Health Harms From Chemicals And a watchdog found they were retaliated against Sep 22, 2024
Women With MS Less Likely to Receive Treatment Than Men Is "therapeutic inertia" to blame? Sep 21, 2024
Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early Starting monoclonal antibody therapy during childhood reduced long-term disability Sep 20, 2024
First Drug Approved for Niemann-Pick Disease Type C Arimoclomol (Miplyffa) greenlit for ultra-rare genetic disorder Sep 20, 2024
Tolebrutinib Slows Disability in Non-Relapsing Secondary Progressive MS Liver toxicity may still be a concern Sep 20, 2024
Blood Markers Help Predict MS Disease Progression Patients with high NfL at disease onset may benefit from high-efficacy treatments Sep 19, 2024
Older Migraine Drugs More Effective Than Newer Ones, Analysis Suggests Triptans are efficacious and underused, researchers say Sep 18, 2024
Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes Analysis looks at pooled data of 17,000 MS trial participants Sep 18, 2024
Brain Training and Memory Decline; Alzheimer's Pioneer Dies; Notorious APOE4 News and commentary from the world of neurology and neuroscience Sep 17, 2024
Microplastics Found in Human Olfactory Bulbs Findings suggest a pathway for plastic fragments to enter the brain Sep 16, 2024
Scientists Show How Pregnancy Changes the Brain in Innumerable Ways Research could provide clues about disorders like postpartum depression Sep 16, 2024
Brain Health Risks: Digital Quality Measures and the Future of Neurological Care Access to advanced tools must be equitable Sep 16, 2024
The 'Jennifer Aniston Neuron' and Other Brain Complexities In his new book, Theodore Schwartz, MD, immerses readers in the story of brain surgery Sep 13, 2024
Alzheimer's and X Chromosomes; Identifying Pediatric MOGAD; Vladimir Lenin's Death News and commentary from the world of neurology and neuroscience Sep 10, 2024
NIH Stops Havana Syndrome Study After Investigating Coercion Claims Regulatory, policy requirements not met, agency says Sep 09, 2024
Should We Attribute Patients' Conditions to 'Old Age'? Fueling denial of the realities of aging comes at a great cost Sep 07, 2024
Upper GI Damage Tied to Subsequent Parkinson's Disease Mucosal damage seen on upper endoscopy associated with 76% higher Parkinson's risk Sep 06, 2024
